Is Screening for Hepatitis Necessary in Diagnostic Evaluation of Rheumatoid Arthritis in South Korea?

To the Editor:
We read with interest the article by Guennoc, et al 1 reporting that seroprevalences of hepatitis B (HBV) and hepatitis C (HCV) in patients with recent-onset polyarthritis who were suspected of rheumatoid arthritis (RA), were very low and were not different compared to the general population. Thus, they proposed that serological testing for HBV and HCV is unnecessary in routine diagnostic evaluation for these patients. Currently in our institution, simultaneous serological testing for HBV and HCV and even hepatitis A (HAV) is performed on patients suspected of RA as part of a routine diagnostic evaluation. We performed this study to also check the usefulness of such routine diagnostic evaluation of hepatitis.
We investigated the hepatitis test results in patients who visited The Hospital for Rheumatic Diseases and were diagnosed with RA during an 8-year period, from January 2001 to December 2008. Hepatitis B surface antigen (HBsAg)-positive was found in 3.5% of patients (140/3946), while anti-HCV-positive was found in 1.1% of patients (38/3448). The HAV-IgM test used for the diagnosis of HAV was positive in 3.77% of patients (140/2594). Looking at the yearly trend of positive rates, there was a decreasing trend for HBsAg, but no large change was seen for anti-HCV (Figure 1 ). For HAV, yearly positive rates showed large fluctuations and there was an abrupt increase in 2008 ( Figure 2) .
Korea had high HBsAg-positive rates of 7% to 8% in the 1980s, but the figures fell to 4.4% in men and 3.0% in women in 2005 through continuous vaccination programs 2 . These figures did not differ much from the results we obtained from patients with RA. However, the positive rate was higher than the result reported by Guennoc, et al (0.86%). The anti-HCV-positive rate was known to be around 1% in Korean adults 2 , and this was similar to our result. However, the positive rate was lower than the anti-HCV result reported by them.
As Korea achieved rapid economic development since the mid-1970s, changes appeared in the positive rate of the HAV antibody. According to data from the end of the 1970s, 100% of the domestic population above age 15 had the antibody, but by the end of the 1990s there was a distinct decrease. In people under age 20 years, the positive rate was a very low 20%. The rate was 40%-60% for ages 20-30, and 80%-90% for those 
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